Home » Topics » Science » New compound

New compound
RSS

Thrombin inhibitors submitted to SAR studies at DuPont Merck

Jan. 24, 1997

Glaxo Wellcome selects anticonvulsant compound for further study

Jan. 24, 1997

New tool for studying phosphodiesterase receptors

Jan. 23, 1997

New AMPA receptor modulator described by Servier

Jan. 23, 1997

Neuroprotective agent described by Taisho

Jan. 16, 1997

Schering-Plough develops dual PAF and histamine antagonist

Jan. 16, 1997

New analgesic agent described by Japanese academics

Jan. 10, 1997

New manumycin-class antibiotics isolated at Tanabe Seiyaku

Jan. 10, 1997

Korean researchers report new immunosuppressant from natural source

Jan. 10, 1997

Antileukemic bisabolane sesquiterpene isolated from natural sources

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...